Association of HLA-A*11:01 with Sulfonamide-Related Severe Cutaneous Adverse Reactions in Japanese Patients

J Invest Dermatol. 2020 Aug;140(8):1659-1662.e6. doi: 10.1016/j.jid.2019.12.025. Epub 2020 Jan 23.

¹ Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan.
² Laboratory for Pharmacogenomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
³ Institute of Advanced Biosciences, Tokai University, Kanagawa, Japan.
⁴ Center for Preventive Medical Science, Chiba University, Chiba, Japan.
⁵ Department of Dermatology, Kyorin University School of Medicine, Tokyo, Japan.
⁶ Department of Dermatology, Showa University School of Medicine, Tokyo, Japan.
⁷ Department of Dermatology, Nara Medical University, Nara, Japan.
⁸ Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Aichi, Japan.
⁹ Department of Dermatology, Shimane University Faculty of Medicine, Shimane, Japan.
¹⁰ Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
¹¹ Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan. Electronic address: yoshiro@nihs.go.jp.

No abstract available

Publication types